All In Biotech

Free tool

FAERS Monitor: Venclexta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208573 or its brand name (Venclexta, Venetoclax). Reports on generic versions are filed under their own applications.

Reports

62,878

Serious

56,926

91% of reports

Hospitalization

24,262

Death reported

17,658

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death10,347
  • off label use7,028
  • neutropenia3,635
  • febrile neutropenia3,178
  • myelosuppression3,045
  • platelet count decreased2,936
  • pyrexia2,849
  • pneumonia2,733
  • fatigue2,723
  • diarrhoea2,438
  • white blood cell count decreased2,384
  • thrombocytopenia2,281
  • nausea2,182
  • anaemia2,090
  • infection2,017

Reports by year received

View as table
YearReports
20144
201523
2016691
20171,800
20183,586
20195,067
20205,631
20216,270
202211,152
20238,891
20247,506
20257,297
20264,960

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,281 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal3,04530.829.780,479
febrile neutropeniaSignal3,17816.816.245,033
platelet count decreasedSignal2,9369.49.121,666
neutropeniaSignal3,6359.28.925,879
white blood cell count decreasedSignal2,3847.57.213,196
thrombocytopeniaSignal2,2816.96.711,425
infectionSignal2,0174.74.55,855
deathSignal10,3474.14.024,522
anaemiaSignal2,0903.73.54,098
pneumoniaSignal2,7332.82.73,277
pyrexiaSignal2,8492.82.73,244
off label useSignal7,0282.72.67,775
diarrhoea2,4381.31.2138
fatigue2,7231.21.170
nausea2,1820.90.915

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.